buprenorphine transdermal system
NDC 47781-408 · Alvogen Inc.
Generic namebuprenorphine
Dosage formPATCH, EXTENDED RELEASE
RouteTRANSDERMAL
Active ingredient(s)BUPRENORPHINE
Strength20 ug/h
Pharmacologic classPartial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]
DEA scheduleCIII
Marketing categoryANDA
Packages
47781-408-04 — 4 POUCH in 1 CARTON (47781-408-04) / 1 PATCH in 1 POUCH (47781-408-11) / 168 h in 1 PATCH
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
3215-1523 — Buprenorphine, 3215-1524 — Buprenorphine, 3215-1525 — Buprenorphine, 42858-353 — Buprenorphine, 42858-493 — Buprenorphine, 42858-586 — Buprenorphine, 42858-750 — Buprenorphine, 42858-839 — Buprenorphine, 47781-406 — buprenorphine, 47781-407 — buprenorphine, 47781-419 — buprenorphine, 50742-372 — Buprenorphine, 50742-373 — Buprenorphine, 50742-374 — Buprenorphine, 50742-375 — Buprenorphine, 50742-376 — Buprenorphine, 58064-408 — buprenorphine, 58284-208 — BUPRENORPHINE, 58284-216 — BUPRENORPHINE, 58284-224 — BUPRENORPHINE, +27 more